5-Fluorouracil Impairs Transmission of Acetylcholine in the Hippocampus and Induces Cognitive Impairments in Mice
Background: Chemotherapy-induced cognitive impairments are a significant adverse sequela of cancer treatment. The potential mechanism of chemotherapy-induced cognitive impairments remains elusive. The present study evaluated the impact of a commonly utilized chemotherapy agent, 5-fluorouracil (5-FU)...
Saved in:
| Published in | Journal of integrative neuroscience Vol. 24; no. 4; pp. 26903 - 10 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Singapore
IMR Press
18.04.2025
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Background: Chemotherapy-induced cognitive impairments are a significant adverse sequela of cancer treatment. The potential mechanism of chemotherapy-induced cognitive impairments remains elusive. The present study evaluated the impact of a commonly utilized chemotherapy agent, 5-fluorouracil (5-FU), on acetylcholine (ACh) levels in the hippocampus. Methods: 5-FU was injected into mice once a day for 10 days to create a mouse model of chemotherapy-induced cognitive impairment. Microdialysis and HPLC-MS/MS were used to determine hippocampal ACh levels. Biocytin injection and patch-clamp recordings were performed on cholinergic (ChAT) neurons in the medial septum (MS) to observe their morphological and electrophysiological changes. Chemogenetic tools were used to activate ChAT neurons in the MS. The acetylcholinesterase inhibitor donepezil was injected i.p. into mice to elevate ACh levels in the brain. Results: Cognitive performance in mice was impaired after 5-FU treatment, accompanied by reduced ACh release in the hippocampus. The administration of 5-FU led to compromised structural integrity and diminished activity of ChAT neurons in the MS. Chemogenetic stimulation of MS ChAT neurons ameliorated the cognitive impairments. The administration of donepezil also reduced the cognitive impairments caused by 5-FU. Conclusions: 5-FU therapy caused cognitive impairments in mice by affecting the neuronal structure and activity of ChAT neurons in the MS. Inducing the increase of ACh levels could be a promising therapeutic approach for addressing 5-FU treatment-induced cognitive impairments. |
|---|---|
| AbstractList | Background: Chemotherapy-induced cognitive impairments are a significant adverse sequela of cancer treatment. The potential mechanism of chemotherapy-induced cognitive impairments remains elusive. The present study evaluated the impact of a commonly utilized chemotherapy agent, 5-fluorouracil (5-FU), on acetylcholine (ACh) levels in the hippocampus. Methods: 5-FU was injected into mice once a day for 10 days to create a mouse model of chemotherapy-induced cognitive impairment. Microdialysis and HPLC-MS/MS were used to determine hippocampal ACh levels. Biocytin injection and patch-clamp recordings were performed on cholinergic (ChAT) neurons in the medial septum (MS) to observe their morphological and electrophysiological changes. Chemogenetic tools were used to activate ChAT neurons in the MS. The acetylcholinesterase inhibitor donepezil was injected i.p. into mice to elevate ACh levels in the brain. Results: Cognitive performance in mice was impaired after 5-FU treatment, accompanied by reduced ACh release in the hippocampus. The administration of 5-FU led to compromised structural integrity and diminished activity of ChAT neurons in the MS. Chemogenetic stimulation of MS ChAT neurons ameliorated the cognitive impairments. The administration of donepezil also reduced the cognitive impairments caused by 5-FU. Conclusions: 5-FU therapy caused cognitive impairments in mice by affecting the neuronal structure and activity of ChAT neurons in the MS. Inducing the increase of ACh levels could be a promising therapeutic approach for addressing 5-FU treatment-induced cognitive impairments. Chemotherapy-induced cognitive impairments are a significant adverse sequela of cancer treatment. The potential mechanism of chemotherapy-induced cognitive impairments remains elusive. The present study evaluated the impact of a commonly utilized chemotherapy agent, 5-fluorouracil (5-FU), on acetylcholine (ACh) levels in the hippocampus.BACKGROUNDChemotherapy-induced cognitive impairments are a significant adverse sequela of cancer treatment. The potential mechanism of chemotherapy-induced cognitive impairments remains elusive. The present study evaluated the impact of a commonly utilized chemotherapy agent, 5-fluorouracil (5-FU), on acetylcholine (ACh) levels in the hippocampus.5-FU was injected into mice once a day for 10 days to create a mouse model of chemotherapy-induced cognitive impairment. Microdialysis and HPLC-MS/MS were used to determine hippocampal ACh levels. Biocytin injection and patch-clamp recordings were performed on cholinergic (ChAT) neurons in the medial septum (MS) to observe their morphological and electrophysiological changes. Chemogenetic tools were used to activate ChAT neurons in the MS. The acetylcholinesterase inhibitor donepezil was injected i.p. into mice to elevate ACh levels in the brain.METHODS5-FU was injected into mice once a day for 10 days to create a mouse model of chemotherapy-induced cognitive impairment. Microdialysis and HPLC-MS/MS were used to determine hippocampal ACh levels. Biocytin injection and patch-clamp recordings were performed on cholinergic (ChAT) neurons in the medial septum (MS) to observe their morphological and electrophysiological changes. Chemogenetic tools were used to activate ChAT neurons in the MS. The acetylcholinesterase inhibitor donepezil was injected i.p. into mice to elevate ACh levels in the brain.Cognitive performance in mice was impaired after 5-FU treatment, accompanied by reduced ACh release in the hippocampus. The administration of 5-FU led to compromised structural integrity and diminished activity of ChAT neurons in the MS. Chemogenetic stimulation of MS ChAT neurons ameliorated the cognitive impairments. The administration of donepezil also reduced the cognitive impairments caused by 5-FU.RESULTSCognitive performance in mice was impaired after 5-FU treatment, accompanied by reduced ACh release in the hippocampus. The administration of 5-FU led to compromised structural integrity and diminished activity of ChAT neurons in the MS. Chemogenetic stimulation of MS ChAT neurons ameliorated the cognitive impairments. The administration of donepezil also reduced the cognitive impairments caused by 5-FU.5-FU therapy caused cognitive impairments in mice by affecting the neuronal structure and activity of ChAT neurons in the MS. Inducing the increase of ACh levels could be a promising therapeutic approach for addressing 5-FU treatment-induced cognitive impairments.CONCLUSIONS5-FU therapy caused cognitive impairments in mice by affecting the neuronal structure and activity of ChAT neurons in the MS. Inducing the increase of ACh levels could be a promising therapeutic approach for addressing 5-FU treatment-induced cognitive impairments. Chemotherapy-induced cognitive impairments are a significant adverse sequela of cancer treatment. The potential mechanism of chemotherapy-induced cognitive impairments remains elusive. The present study evaluated the impact of a commonly utilized chemotherapy agent, 5-fluorouracil (5-FU), on acetylcholine (ACh) levels in the hippocampus. 5-FU was injected into mice once a day for 10 days to create a mouse model of chemotherapy-induced cognitive impairment. Microdialysis and HPLC-MS/MS were used to determine hippocampal ACh levels. Biocytin injection and patch-clamp recordings were performed on cholinergic (ChAT) neurons in the medial septum (MS) to observe their morphological and electrophysiological changes. Chemogenetic tools were used to activate ChAT neurons in the MS. The acetylcholinesterase inhibitor donepezil was injected i.p. into mice to elevate ACh levels in the brain. Cognitive performance in mice was impaired after 5-FU treatment, accompanied by reduced ACh release in the hippocampus. The administration of 5-FU led to compromised structural integrity and diminished activity of ChAT neurons in the MS. Chemogenetic stimulation of MS ChAT neurons ameliorated the cognitive impairments. The administration of donepezil also reduced the cognitive impairments caused by 5-FU. 5-FU therapy caused cognitive impairments in mice by affecting the neuronal structure and activity of ChAT neurons in the MS. Inducing the increase of ACh levels could be a promising therapeutic approach for addressing 5-FU treatment-induced cognitive impairments. |
| Author | Huang, Xiwen Peng, Shunqing Lan, Yongquan Wu, Jianlin Chen, Wenjun |
| Author_xml | – sequence: 1 givenname: Xiwen orcidid: 0000-0002-6874-2241 surname: Huang fullname: Huang, Xiwen – sequence: 2 givenname: Shunqing orcidid: 0009-0005-2521-9273 surname: Peng fullname: Peng, Shunqing – sequence: 3 givenname: Yongquan orcidid: 0009-0008-7311-8540 surname: Lan fullname: Lan, Yongquan – sequence: 4 givenname: Wenjun orcidid: 0000-0002-9397-3594 surname: Chen fullname: Chen, Wenjun – sequence: 5 givenname: Jianlin orcidid: 0009-0002-6739-5484 surname: Wu fullname: Wu, Jianlin |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40302265$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdkcFu3CAQhlGVqtmkPfQFKqRemoNbYDCYY7RqGldpe0ml3hDGOGFlgwN2pLx9SXaTQ04jRh-fZuY_QUchBofQR0q-AiUNfPvZ_mZCEXiDNlTWsuK8-XeENoRRVQmo2TE6yXlHyhsUeYeOOQHCmKg36K6uLsY1prgmY_2I22k2PmV8nUzIk8_Zx4DjgM-tWx5GextHHxz2AS-3Dl_6eY7WTPOasQk9bkO_WpfxNt4Ev_h7d9BNLiz58dMvb9179HYwY3YfDvUU_b34fr29rK7-_Gi351eVBSmWygo7UCWl7Y2DmgwDkJpwOhDphOqVAC77sgwQWQAlDVMDY9AIZyztBujgFLV7bx_NTs_JTyY96Gi8fmrEdKNNWrwdnZaGNKShBCyhnEupuKBNZxWQoZMdheL6snfNKd6tLi-6nMa6cTTBxTVrKJMKXkuuCvr5Fbortw1lUw2Msaaua3gUfjpQaze5_mW852AKcLYHbIo5Jze8IJTop9D1c-jwH98FnCo |
| Cites_doi | 10.1016/j.cell.2016.10.021. 10.1126/science.1238411. 10.1016/j.bbr.2010.11.037. 10.1016/j.expneurol.2024.114949. 10.1007/s00213-010-2122-2. 10.1093/jnci/djj470. 10.1007/978-1-4419-6306-2_13. 10.1038/npp.2013.274. 10.1038/s41571-022-00685-3. 10.1002/cam4.2069. 10.1038/s41380-023-01949-9. 10.1016/j.neuron.2012.08.036. 10.1039/d1fo03055h. 10.1007/s00441-017-2745-2. 10.1111/j.1460-9568.2008.06325.x. 10.1002/(sici)1097-0142(19990201)85:3 10.4103/1673-5374.371369. 10.1038/clpt.2011.112. 10.1002/cncr.25098. 10.1093/brain/awac096. 10.1038/nn.4661. 10.1016/j.ctrv.2012.05.002. 10.1016/j.brainresbull.2021.07.030. 10.1002/ana.410140310. 10.1136/bmj.l6217. 10.3816/CBC.2008.n.006. 10.1002/cncr.22610. 10.1016/j.bbi.2024.03.015. 10.1016/S1470-2045(10)70294-1. 10.3390/nu10081053. 10.1126/scitranslmed.adf8977. 10.1016/j.pharmthera.2019.107447. 10.2325/jbcs.12.279. 10.3390/ph16081082. 10.1016/j.ejmech.2023.115476. 10.1186/s11658-021-00294-5. 10.1200/JCO.2004.08.094. 10.3816/cbc.2002.s.023. 10.1016/s0301-0082(00)00058-7. 10.1016/j.lfs.2020.117468. 10.1007/978-1-4419-6306-2_20. 10.1038/nrc1074. 10.1016/j.neuron.2016.09.006. 10.1016/j.brainresbull.2012.05.005. 10.1016/j.biopsych.2022.04.019. 10.1038/s41467-017-01943-0. 10.1126/sciadv.ado1508. 10.1093/annonc/mdw271. 10.1016/j.bbr.2017.03.042. |
| ContentType | Journal Article |
| Copyright | 2025 The Author(s). Published by IMR Press. Copyright IMR Press 2025 |
| Copyright_xml | – notice: 2025 The Author(s). Published by IMR Press. – notice: Copyright IMR Press 2025 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7QR 7TK 8FD 8FE 8FH ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 GNUQQ HCIFZ LK8 M7P P64 PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 DOA |
| DOI | 10.31083/JIN26903 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Chemoreception Abstracts Neurosciences Abstracts Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database ProQuest Central Student SciTech Premium Collection Biological Sciences Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Biotechnology Research Abstracts Natural Science Collection ProQuest Central Korea Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts Biotechnology and BioEngineering Abstracts ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| EISSN | 1757-448X |
| EndPage | 10 |
| ExternalDocumentID | oai_doaj_org_article_7a0808103c01447794618bc930fb7b13 40302265 10_31083_JIN26903 |
| Genre | Journal Article |
| GeographicLocations | Guangzhou China China |
| GeographicLocations_xml | – name: Guangzhou China – name: China |
| GrantInformation_xml | – fundername: Guangdong Basic and Applied Basic Research Foundation grantid: 2022A1515011987 |
| GroupedDBID | --- 0R~ 36B 4.4 53G 5GY AAFWJ AAYXX ACIWK ACPQW ACPRK ADZMO AENEX AFKRA AFPKN AFRAH AFRHK AJNRN ALMA_UNASSIGNED_HOLDINGS BBNVY BENPR BHPHI CAG CCPQU CITATION COF CS3 DU5 EBS EJD EMOBN F5P GROUPED_DOAJ HCIFZ HZ~ IL9 IOS J8X M7P O9- P2P P71 PHGZM PHGZT PIMPY RWJ SAUOL SCNPE SFC SJN W2D CGR CUY CVF ECM EIF NPM 7QO 7QR 7TK 8FD 8FE 8FH ABUWG AZQEC DWQXO FR3 GNUQQ LK8 P64 PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 |
| ID | FETCH-LOGICAL-c376t-c6cf1977cdae350ff305041f07e69d96347d390307dae97a29f22386eac1bf3b3 |
| IEDL.DBID | DOA |
| ISSN | 0219-6352 |
| IngestDate | Wed Aug 27 01:20:57 EDT 2025 Fri Jul 11 18:42:46 EDT 2025 Fri Jul 25 09:18:10 EDT 2025 Thu May 01 02:19:58 EDT 2025 Tue Jul 01 05:04:20 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | 5-fluorouracil cholinergic neurons acetylcholine medial septum cognitive impairments |
| Language | English |
| License | https://creativecommons.org/licenses/by/4.0 2025 The Author(s). Published by IMR Press. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c376t-c6cf1977cdae350ff305041f07e69d96347d390307dae97a29f22386eac1bf3b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0009-0005-2521-9273 0009-0002-6739-5484 0009-0008-7311-8540 0000-0002-9397-3594 0000-0002-6874-2241 |
| OpenAccessLink | https://doaj.org/article/7a0808103c01447794618bc930fb7b13 |
| PMID | 40302265 |
| PQID | 3222855533 |
| PQPubID | 2047844 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_7a0808103c01447794618bc930fb7b13 proquest_miscellaneous_3197645749 proquest_journals_3222855533 pubmed_primary_40302265 crossref_primary_10_31083_JIN26903 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2025-04-18 |
| PublicationDateYYYYMMDD | 2025-04-18 |
| PublicationDate_xml | – month: 04 year: 2025 text: 2025-04-18 day: 18 |
| PublicationDecade | 2020 |
| PublicationPlace | Singapore |
| PublicationPlace_xml | – name: Singapore – name: Amsterdam |
| PublicationTitle | Journal of integrative neuroscience |
| PublicationTitleAlternate | J Integr Neurosci |
| PublicationYear | 2025 |
| Publisher | IMR Press |
| Publisher_xml | – name: IMR Press |
| References | ref13 ref12 ref15 ref14 ref11 ref10 ref17 ref16 ref19 ref18 ref46 ref45 ref48 ref47 ref42 ref41 ref44 ref43 ref49 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 ref35 ref34 ref37 ref36 ref31 ref30 ref33 ref32 ref2 ref1 ref39 ref38 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 |
| References_xml | – ident: ref46 doi: 10.1016/j.cell.2016.10.021. – ident: ref45 doi: 10.1126/science.1238411. – ident: ref21 doi: 10.1016/j.bbr.2010.11.037. – ident: ref29 doi: 10.1016/j.expneurol.2024.114949. – ident: ref47 doi: 10.1007/s00213-010-2122-2. – ident: ref37 doi: 10.1093/jnci/djj470. – ident: ref3 doi: 10.1007/978-1-4419-6306-2_13. – ident: ref28 doi: 10.1038/npp.2013.274. – ident: ref2 doi: 10.1038/s41571-022-00685-3. – ident: ref5 doi: 10.1002/cam4.2069. – ident: ref24 doi: 10.1038/s41380-023-01949-9. – ident: ref19 doi: 10.1016/j.neuron.2012.08.036. – ident: ref41 doi: 10.1039/d1fo03055h. – ident: ref22 doi: 10.1007/s00441-017-2745-2. – ident: ref15 doi: 10.1111/j.1460-9568.2008.06325.x. – ident: ref14 doi: 10.1002/(sici)1097-0142(19990201)85:3 – ident: ref30 doi: 10.4103/1673-5374.371369. – ident: ref39 doi: 10.1038/clpt.2011.112. – ident: ref36 doi: 10.1002/cncr.25098. – ident: ref33 doi: 10.1093/brain/awac096. – ident: ref43 doi: 10.1038/nn.4661. – ident: ref8 doi: 10.1016/j.ctrv.2012.05.002. – ident: ref31 doi: 10.1016/j.brainresbull.2021.07.030. – ident: ref18 doi: 10.1002/ana.410140310. – ident: ref34 doi: 10.1136/bmj.l6217. – ident: ref13 doi: 10.3816/CBC.2008.n.006. – ident: ref7 doi: 10.1002/cncr.22610. – ident: ref32 doi: 10.1016/j.bbi.2024.03.015. – ident: ref4 doi: 10.1016/S1470-2045(10)70294-1. – ident: ref48 doi: 10.3390/nu10081053. – ident: ref25 doi: 10.1126/scitranslmed.adf8977. – ident: ref35 doi: 10.1016/j.pharmthera.2019.107447. – ident: ref6 doi: 10.2325/jbcs.12.279. – ident: ref10 doi: 10.3390/ph16081082. – ident: ref11 doi: 10.1016/j.ejmech.2023.115476. – ident: ref26 doi: 10.1186/s11658-021-00294-5. – ident: ref40 doi: 10.1200/JCO.2004.08.094. – ident: ref42 doi: 10.3816/cbc.2002.s.023. – ident: ref44 doi: 10.1016/s0301-0082(00)00058-7. – ident: ref38 doi: 10.1016/j.lfs.2020.117468. – ident: ref12 doi: 10.1007/978-1-4419-6306-2_20. – ident: ref9 doi: 10.1038/nrc1074. – ident: ref20 doi: 10.1016/j.neuron.2016.09.006. – ident: ref17 doi: 10.1016/j.brainresbull.2012.05.005. – ident: ref49 doi: 10.1016/j.biopsych.2022.04.019. – ident: ref23 doi: 10.1038/s41467-017-01943-0. – ident: ref27 doi: 10.1126/sciadv.ado1508. – ident: ref1 doi: 10.1093/annonc/mdw271. – ident: ref16 doi: 10.1016/j.bbr.2017.03.042. |
| SSID | ssj0021390 |
| Score | 2.3497508 |
| Snippet | Background: Chemotherapy-induced cognitive impairments are a significant adverse sequela of cancer treatment. The potential mechanism of chemotherapy-induced... Chemotherapy-induced cognitive impairments are a significant adverse sequela of cancer treatment. The potential mechanism of chemotherapy-induced cognitive... |
| SourceID | doaj proquest pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database |
| StartPage | 26903 |
| SubjectTerms | 5-Fluorouracil acetylcholine Acetylcholine - metabolism Acetylcholinesterase Animals Antimetabolites, Antineoplastic - toxicity Biocytin Cancer therapies Chemotherapy Chemotherapy-Related Cognitive Impairment - etiology Chemotherapy-Related Cognitive Impairment - metabolism Chemotherapy-Related Cognitive Impairment - physiopathology cholinergic neurons Cholinergic Neurons - drug effects Cholinergic Neurons - metabolism Cholinergics Cholinesterase inhibitors Cholinesterase Inhibitors - pharmacology Cognitive ability Cognitive Dysfunction - chemically induced Cognitive Dysfunction - metabolism cognitive impairments Disease Models, Animal Donepezil Donepezil - pharmacology Fluorouracil - toxicity Hippocampus Hippocampus - drug effects Hippocampus - metabolism Male medial septum Medical research Mice Mice, Inbred C57BL Microdialysis Neurons Structural integrity Synaptic Transmission - drug effects |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwELba5dJLRQuFpbRyK9SbRZyX7VO1IFYLEquqKhK3yHZstNKShH0c-PfMOM5WHNpr4ljRjOebb8b2DCFnynqTcJ2wXGsPAYr3TIPfZiKtHbpL7jVecL6dl7O7_Oa-uI8Jt3U8VjlgYgDqurWYIz_HHQFZFMBOfnZPDLtG4e5qbKHxluwBBEs5InsXV_Nfv3chF_CbPsvCFQPXmva1hYDSyOz85nqeQmyYvfJIoXD_v9lm8DrTffI-0kU66fX7gbxxzUdyMGkgVH58pj9oOMAZMuMH5Klg0-W2XcE32i6W9BosfbFa0-COQJ2YF6OtpxPrNs9LhD1gmHTRUOCAdLboOnBrj912TXVTU2zpARBCL4fjRXG6cCMOP7oFhDkkd9OrP5czFjsqMAtAsmG2tJ4D47O1dlkBigFrT3LuE-FKVYMt5qIGiYHdwwAldKo80AdZAjpz4zOTfSKjpm3cMaHe2FI6Xss8w51LZ6zgymrHS2WU8npMvg9Srbq-cEYFAUcQfTWIfkwuUN67AVjrOjxoVw9VNJ1K6ATbgySZxehPYEV8Lo1VWeKNMBwmOR20VUUDXFd_l8uYfNu9BlnjfohuXLuFMSCKMi9ErsbkqNfy7k9yEAIw0-Lk_5N_Ju9SbAiMxR_lKRltVlv3BVjKxnyNS_EFik3mZQ priority: 102 providerName: ProQuest |
| Title | 5-Fluorouracil Impairs Transmission of Acetylcholine in the Hippocampus and Induces Cognitive Impairments in Mice |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40302265 https://www.proquest.com/docview/3222855533 https://www.proquest.com/docview/3197645749 https://doaj.org/article/7a0808103c01447794618bc930fb7b13 |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwEB0huPRStVDatIDcquIWEefL8XFBrBYkVqgqErfIdmxppSW73Y8D_55nJ1mVA-ql18SJrDeZeW9sZ4bopzROJ1wlca6UQ4LiXKzA27FIG-vpkjvlf3C-m5aTh_z2sXj8q9WXPxPWlQfugLsQKvHNIZLMeO0vfD10Xmkjs8RpoUO_2hScNyRTfaoFXdOtrnAZg1LTrqYQpEyVXdzeTFPkhNkrJgoF-99WmYFtxh_ofS8T2aib3kfas-0hHY1apMhPz-ychYObYUX8iP4U8Xi-XazwjDKzObuBh89WaxZoCGb062Fs4djI2M3z3Ic7KEs2axm0H5vMlkvQ2dNyu2aqbZhv5YHQwa6GY0X968KfcP6hO0SWT_Qwvv59NYn7TgqxQQDZxKY0jkPpmUbZrIBB4OVJzl0ibCkb-GAuGiAGf8cAKVQqHWRDVSIqc-0ynR3Tfrto7RdiTpuysryp8szvWFptBJdGWV5KLaVTEf0YUK2XXcGMGolGgL4eoI_o0uO9G-BrXIcLsHzdW77-l-UjOhmsVfeOt679xlFVFBCxEX3f3QbWfh9EtXaxxRhAUeaFyGVEnzsr72aSAwQo0uLr_5jhN3qX-nbBvjRkdUL7m9XWnkLDbPQZHVxeT-9_nYXP9gW9we1F |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6V9AAXVCjQQAGDgNuq6_W-fEAoLY2StokQaqXeFttro0jp7jYPVflT_EZm9hHEAW697tojazyPbzz2DMAHaZz2ufK9UCmHAYpznkK_7SVBbsldcqfogfNkGo-uwrPr6HoHfnVvYehaZWcTa0Odl4bOyI8oI5BGEaKTL9WtR12jKLvatdBoxOLcbu4wZFt-Hn_F_f0YBMPTy5OR13YV8Awq08ozsXEcUY_JlRURLg4l3g-58xMbyxzlMUxyIUn2cYBMVCAdutA0RgvFtRNaIN0HsBuK2A96sHt8Ov32fRviIZ5qTnW49NCVB00tI4RQqTg6G08DjEXFXx6wbhTwb3Rbe7nhHjxu4SkbNPL0BHZs8RT2BwWG5jcb9onVF0brk_h9uI284XxdLnCOMrM5G6NlmS2WrHZ_KD50DsdKxwbGrjZzMrOIaNmsYIg52WhWVehGb6r1kqkiZ9RCBE0WO-muM7Xk6hd4NGmCFu0ZXN0Lr59DrygLewDMaROnludpKChTarVJuDTK8lhqKZ3qw_uOq1nVFOrIMMCpWZ91rO_DMfF7O4Bqa9cfysXPrFXVLFE-tSPxhaFoM6EK_DzVRgrf6URzJHLY7VbWKvwy-yOefXi3_Y28pvyLKmy5xjHIijiMklD24UWzy9uVhMgERMLRy_8TfwsPR5eTi-xiPD1_BY8CakZMhSfTQ-itFmv7GhHSSr9pxZLBj_vWhN_kESMt |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=5-Fluorouracil+Impairs+Transmission+of+Acetylcholine+in+the+Hippocampus+and+Induces+Cognitive+Impairments+in+Mice&rft.jtitle=Journal+of+integrative+neuroscience&rft.au=Xiwen+Huang&rft.au=Shunqing+Peng&rft.au=Yongquan+Lan&rft.au=Wenjun+Chen&rft.date=2025-04-18&rft.pub=IMR+Press&rft.issn=0219-6352&rft.volume=24&rft.issue=4&rft.spage=26903&rft_id=info:doi/10.31083%2FJIN26903&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_7a0808103c01447794618bc930fb7b13 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0219-6352&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0219-6352&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0219-6352&client=summon |